ArticleCureus2024
Charcot-Marie-Tooth Disease Presenting in the Postpartum Period: A Case Report.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Charcot-Marie-Tooth disease (CMT) is the most common hereditary peripheral neuropathy. It presents a wide range of genetic and phenotypic heterogeneity. CMT disease type 1A (CMT1A), caused by PMP22 gene duplication, represents the most common subtype of CMT in Western countries. It usually presents insidiously with stigmata of chronic neuropathy. We report a rare case of CMT1A, which presents acutely in the postpartum period. A young woman who experienced acute bilateral lower limb numbness and weakness post-caesarean section, which was initially attributed to spinal anaesthesia. The initial work-up was normal, but subsequent nerve conduction studies indicated a possibility of hereditary, demyelinating sensory-motor neuropathy. Genetic testing confirmed the diagnosis of CMT1A. The article explores the effects of pregnancy on patients with CMT in terms of potential worsening or unmasking of CMT symptoms and the development of obstetric complications in these patients. It also sheds some light on the role of electrophysiological studies and various biomarkers to differentiate between acquired and hereditary neuropathy. In conclusion, it emphasizes the importance of considering hereditary neuropathies in the differential diagnosis of acute atypical neurological presentation during the postpartum period.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.